AbbVie Inc: director Edward J. Rapp received 129 shares

What happened Edward J. Rapp, a director, received a grant of 129 derivative shares at $261.59 per share on Sep 30, 2026, valued at $33,745, according to the Form 4.

Key details

• Transaction date and price: Sep 30, 2026 @ $261.59 per share.
• Transaction type: Grant/award or other acquisition (derivative).
• Shares acquired: 129 shares; total value $33,745.
• Shares owned after the transaction: not specified in the filing provided.
• Relevant footnotes from the filing:
  • F1: Director fees credited to a stock equivalent unit account under the director's grantor trust are distributed over a period equal to the director's years of board service, generally commencing at the later of age 65 or upon retirement from the board; the stock equivalent units earn the same return as if the fees were invested in AbbVie stock.
  • F2: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.
• Filing date/accession: filed Oct 2, 2026 (Accession 0001171780-26-000014). The filing does not indicate late filing status in the information provided.

Why it may matter

• The Form 4 reports a derivative award of stock equivalent units tied to director compensation rather than an open-market purchase or sale.
• This filing does not show why the insider traded or why the company acted.